Italy to increase tobacco prices in 2023

Dec.27.2022
Italian tobacco products will face a price hike in 2023 due to tax changes, affecting cigarette and e-cigarette users.

Smokers in Italy received some bad news as tobacco products will experience a price hike in 2023. The reason for this is due to a revision included in the 2023 budget law, which aims to reshuffle consumption taxes between different products through changes in taxes.

 

As we mentioned earlier, tobacco product users can expect to see a hike in the prices of their vice in 2023. According to the latest developments, a provision increasing the specific consumption tax on cigarettes has been approved by the executive branch led by President Meloni in the 2023 Budget Act. Starting January 1st, 2023, each pack of cigarettes will see a price increase of €0.20 (approximately RMB 1.48), with varying degrees of increment depending on the brand.

 

But that's not all. In 2024, the increase in cigarette prices will continue, with an additional raise of 0.10 or 0.15 euros after the growth in 2023. In other words, starting in 2024, cigarettes may cost an extra 35 cents (about 2.24 yuan) per pack.

 

In 2023, the growth is not only targeted at cigarette users, but also affects those who use electronic cigarettes, such as heated tobacco. However, for this type of cigarette, the increase in price is relatively small, with non-nicotine cigarettes costing approximately 0.08 euros per milliliter (about 0.59 yuan), while nicotine-containing cigarettes will rise to 0.13 euros (about 0.96 yuan).

 

The government's recent estimate projects that Italy could collect at least 100 million euros annually as the price of cigarettes and tobacco is set to increase by 2023.

 

It has been announced that cigarettes and tobacco will increase in price in 2023, but what will their prices be in 2021, with the introduction of the euro? The official website of the State Monopoly Agency for Customs and Excise has released a list of cigarette prices, including all brands available to the public, updated as of November 24th of this year. We can see that in 2022, a pack of cigarettes will cost between 4.8 and 6 euros.

 

Considering the rise in cigarette and tobacco prices in 2023, lower-priced cigarette packs may need to cost 5 euros, while higher-priced packs could even cost 6.20 euros. But what were cigarette prices in 2001? At that time, MS cost 2.17 euros, Camel increased to 2.48 euros, and the most popular brand, Marlboro, was priced at 3 euros. In short, over the last 20 years, cigarette prices have increased by more than 2 euros.

 

Let's take a look at who will spend more money next year in Italy, as cigarettes and tobacco prices are set to increase in 2023.

 

According to data analysis from Epicentre ISS, we can estimate that Italian regions will spend more money on cigarette and tobacco packaging next year due to the Meloni government's plan to increase prices in 2023, based on a two-year period from 2020-2021.

 

In Italy, where do people smoke the most? Among the regions with the highest smoking rates, the top ranking is held by certain areas in central and southern Italy, particularly Abruzzo, Umbria, and Campania, but there are also significant numbers of smokers in Emilia-Romagna.

 

On the contrary, in 2023, the regions of Puglia, Marche, Calabria and Friuli-Venezia Giulia will be less affected by the increase in cigarette and tobacco prices.

 

Data from the Istituto Superiore di Sanità reveals that in Italy, 50% of the population does not smoke, while 24.5% have a habitual consumption of cigarettes.

 

With the awareness that cigarettes and tobacco will increase in price in 2023, let's take a look at how much revenue the country generates from cigarette sales. In this scenario, data from 2020 from the demographic analysis institution, Eurispes, reveal that the country collects approximately 14 billion euros yearly from cigarette sales.

 

However, it is important to note that if we consider the expenses borne by the country itself on an annual basis to support public health measures, prevent and treat diseases related to tobacco consumption, the net profit is actually half of this figure, approximately 7 billion euros.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

China Tobacco Yunnan files patent for cellulose-free nicotine pouch scaffold to replace microcrystalline cellulose
China Tobacco Yunnan files patent for cellulose-free nicotine pouch scaffold to replace microcrystalline cellulose
China Tobacco Yunnan Industrial Co., Ltd. has filed a patent application for a cellulose-free scaffold material for nicotine pouches, proposing a combination of bioceramic material, polydextrose and sugar alcohols to replace conventional microcrystalline cellulose and cellulose derivatives. The filing aims to address issues including powdery mouthfeel, residue and limited release control, while also reducing reliance on existing cellulose-based patent portfolios. In patent examples, one fast-release formulation reached a nicotine release rate of 50% at 10 minutes and more than 90% at 20 minutes.
Sep.02
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Technology reported FY2026 revenue of about $96 million, down 24.7% year over year, as U.S. cannabis-vapor hardware and European e-cigarette sales declined by $17.4 million and $12.7 million, respectively. Fourth-quarter revenue rose 32.5% to $26.7 million, while quarterly gross margin fell to 6.3%. For FY2027, the company is prioritizing Malaysia manufacturing and vapor ODM while continuing to develop nicotine pouches, IKE Tech age-verification technology and G-Mesh licensing. Ispire has not separately disclosed the revenue or profit contribution of those newer businesses.
Regulations
Sep.17 by 2Firsts Perspectives
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
At InterTabac 2026 in Dortmund, PMI is presenting multiple brands and products along “The PMI Boulevard,” including IQOS, ZYN, VEEV and Marlboro. On-site images captured by 2Firsts show dedicated spaces including the IQOS Boutique, ZYN Café, PMI Gallery and Marlboro Office
Market
Sep.16 by 2Firsts Perspectives
Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
U.S. Smokeless Tobacco Company, an Altria Group company, has broken ground on an approximately $250 million manufacturing expansion in Hopkinsville, Kentucky. The roughly 270,000-square-foot facility is expected to create more than 200 jobs and absorb processing, manufacturing and packaging operations currently split between Hopkinsville and Nashville, Tennessee. USSTC previously said production at its Nashville facility is expected to wind down by early 2028. The project forms part of Altria’s broader effort to modernize and consolidate its U.S. smokeless tobacco manufacturing network.
Sep.10